Solvay

Impairment-driven effects

25/06/20 -"We have factored in the potential c.€1.5bn impairment on the composites and (shale) oil & gas business, due to the subdued future business expectations. "

PDF page sample
Pages
60
Language
English
Published on
25/06/20
Download
You may also be interested by these reports :
14/07/25
Givaudan remains a preferred defensive option ahead of the 1H25E results
14/07/25
Adjusting for FX change
11/07/25
Our increased optimism for our 2025 projections arises from the minimal impact of the global conflict on gas futures and current prices. We had ...
11/07/25
Strong profit figures despite FX headwind, due to favorable mix effect

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO